Pediatrics

This COVID-19 roundup includes research on an alternative therapy to nirmatrelvir-ritonavir, a vaccine regimen that protects pregnant women and infants against certain variants, pegylated interferon lambda...

Researchers find a strong link between migraine and anxiety, depressive symptoms in children and adolescents.

Following a multicenter study, the FDA has approved the first enzyme replacement therapy in the United States to treat alpha-mannosidosis.

In a recent clinical trial, researchers determined that mothers who took vitamin D supplements during pregnancy reduced the risk of atopic eczema in the baby’s first year.

Researchers collected and analyzed skin tape strips used on the forearms of newborns to determine whether certain biomarkers could potentially predict the development of atopic dermatitis in infants.

The researchers re-evaluated the effects of vitamin D on asthma exacerbation.

Researchers examined the effectiveness of the monoclonal antibody, nirsevimab, in protecting infants from the respiratory syncytial virus (RSV) and RSV lower respiratory tract infection.

After 15 years, the American Academy of Pediatrics has released an updated guideline on the treatment and management of childhood obesity.